ClinicalTrials.Veeva

Menu

Invasive Group A Streptococcal Infection (ISAI)

A

Association Clinique Thérapeutique Infantile du val de Marne

Status

Enrolling

Conditions

Sepsis Due to Streptococcus, Group A
Therapy
Risk Factors
Severe Infection
Medical Complications
Outcome, Fatal
Virulence Factors
Strain
Medical Care

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection

Full description

The main of this study is to identify and record cases of invasive and severe infections due to Streptococcus pyogenes. In order to evaluate the incidence of severe forms of disease and the possible contributing factors, and to optimize their management.

Admitted patients to intensive care or critical care units in reported via Santé Publique France may also be included in this study.

Secondly, epidemiological, clinical, bacteriological data of all severe or not cases, of group A Streptococcal infections will be compiled to describe their characteristics, and try to explain this recrudescence as well as possible.

Enrollment

100 estimated patients

Sex

All

Ages

1 day to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age<18 years
  • Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)

Exclusion criteria

  • Opposition of the patient or his/her legal representative

Trial contacts and locations

1

Loading...

Central trial contact

Levy Corinne; Bechet Stephane

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems